Opus Genetics, Inc. · NASDAQ:IRD

Caligan Partners LP reported a 6.20% stake in Opus Genetics, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Caligan Partners LP reported a 6.20% stake in Opus Genetics, Inc., 5,960,972 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
6.20%
Shares
5,960,972
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP6.20%5,960,972
JOHNSON DAVID EDWARD6.20%5,960,972

Source

Download original · View original at SEC

Related